Company news

D&d Pharmatech Co., Ltd. (KRX:347850) news

D&d Pharmatech Co., Ltd. news releases on 6ix. Latest, Jun 16, 2025: D&D Pharmatech Announces Positive Phase 2 Results for DD01 in MASH with Robust Reductions…

View D&d Pharmatech Co., Ltd. →

Press releases & updates

D&D Pharmatech Announces Positive Phase 2 Results for DD01 in MASH with Robust Reductions in Liver Fat Accompanied by Improvements in Liver and Metabolic Health

June 16, 2025